Abigail Kennedy Grant1, Lauren Golden2. 1. NYU Langone Medical Center, New York, NY, USA. 2. NYU Langone Medical Center, New York, NY, USA. Lauren.Golden@nyulangone.org.
Abstract
PURPOSE OF REVIEW: The increasing prevalence of type 2 diabetes is driving the boundaries of clinical diabetes care outside of the traditional office setting. The purpose of this paper will be to review recent technological advances in the medical management of people with type 2 diabetes, spanning the spectrum of care from access to healthcare providers/educators, to continual virtual support methods, on-line management tools, and technologically integrated medication delivery systems. RECENT FINDINGS: Recent findings support a potential positive impact of technology on access to care, clinical outcomes, convenience, patient well-being, and patient acceptance. This includes the use of Bluetooth-enabled glucose meters, continuous glucose monitors, mHealth apps, smartpens, and insulin pumps. However, there are impediments to the implementation of some technologies due to cost and lack of insurance coverage. There is evidence to support the use of technology to improve the management and treatment of people with type 2 diabetes. Further research is required to demonstrate the long-term clinical benefit and financial viability of technology in the management of type 2 diabetes.
PURPOSE OF REVIEW: The increasing prevalence of type 2 diabetes is driving the boundaries of clinical diabetes care outside of the traditional office setting. The purpose of this paper will be to review recent technological advances in the medical management of people with type 2 diabetes, spanning the spectrum of care from access to healthcare providers/educators, to continual virtual support methods, on-line management tools, and technologically integrated medication delivery systems. RECENT FINDINGS: Recent findings support a potential positive impact of technology on access to care, clinical outcomes, convenience, patient well-being, and patient acceptance. This includes the use of Bluetooth-enabled glucose meters, continuous glucose monitors, mHealth apps, smartpens, and insulin pumps. However, there are impediments to the implementation of some technologies due to cost and lack of insurance coverage. There is evidence to support the use of technology to improve the management and treatment of people with type 2 diabetes. Further research is required to demonstrate the long-term clinical benefit and financial viability of technology in the management of type 2 diabetes.
Authors: Roy W Beck; Tonya D Riddlesworth; Katrina Ruedy; Andrew Ahmann; Stacie Haller; Davida Kruger; Janet B McGill; William Polonsky; David Price; Stephen Aronoff; Ronnie Aronson; Elena Toschi; Craig Kollman; Richard Bergenstal Journal: Ann Intern Med Date: 2017-08-22 Impact factor: 25.391
Authors: Russell E Glasgow; Deanna Kurz; Diane King; Jennifer M Dickman; Andrew J Faber; Eve Halterman; Tim Woolley; Deborah J Toobert; Lisa A Strycker; Paul A Estabrooks; Diego Osuna; Debra Ritzwoller Journal: Patient Educ Couns Date: 2011-09-15
Authors: Lauralee G Maxwell; Michael Shawn McFarland; Jennifer Waymier Baker; Regina F Cassidy Journal: Pharmacotherapy Date: 2016-03-11 Impact factor: 4.705
Authors: Thea J M Kooiman; Martijn de Groot; Klaas Hoogenberg; Wim P Krijnen; Cees P van der Schans; Adriaan Kooy Journal: Comput Inform Nurs Date: 2018-07 Impact factor: 1.985
Authors: Mark A Jarosinski; Balamurugan Dhayalan; Nischay Rege; Deepak Chatterjee; Michael A Weiss Journal: Diabetologia Date: 2021-03-12 Impact factor: 10.122
Authors: Andreas Andersen; Jonatan I Bagger; Samuel K Sørensen; Maria P A Baldassarre; Ulrik Pedersen-Bjergaard; Julie L Forman; Gunnar Gislason; Tommi B Lindhardt; Filip K Knop; Tina Vilsbøll Journal: Cardiovasc Diabetol Date: 2021-12-24 Impact factor: 9.951
Authors: Ana Díez-Fernández; María Dolores Rodríguez-Huerta; Rubén Mirón-González; José Alberto Laredo-Aguilera; Noelia María Martín-Espinosa Journal: Int J Environ Res Public Health Date: 2021-03-18 Impact factor: 3.390